INDICATION

Atrovent® HFA (ipratropium bromide HFA) Inhalation Aerosol is an anticholinergic indicated for the maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.

For US Healthcare Professionals

Prescribing Information Important Safety Information
Help keep airways open - The evidence is strong.
Significant lung function improvement[1] - View data Low incidence of anticholinergic side effects[2] - Learn more Educate your patients about taking Atrovent HFA - Learn more
HFA=hydrofluoroalkane.
Learn more
Atrovent HFA offers established efficacy and safety in COPD treatment[1]
1 Help keep airways open - The evidence is strong.
1 Significant lung function improvement[1] - View data 1 Low incidence of anticholinergic side effects[2] - Learn more Educate your patients about taking Atrovent HFA - Learn more
HFA=hydrofluoroalkane.

IMPORTANT SAFETY INFORMATION

Atrovent® HFA (ipratropium bromide HFA) Inhalation Aerosol is contraindicated in patients with a history of hypersensitivity to ipratropium, other ATROVENT HFA components, or atropine or any of its derivatives.

ATROVENT HFA is not indicated for the initial treatment of acute episodes of bronchospasm, i.e., rescue therapy.

Discontinue ATROVENT HFA at once and consider alternative treatments if hypersensitivity reactions including anaphylaxis or paradoxical bronchospasm occurs.

ATROVENT HFA should be used with caution in patients with narrow-angle glaucoma or urinary retention. Prescribers should instruct patients to consult a physician immediately should any signs or symptoms of narrow-angle glaucoma, or prostatic hyperplasia or bladder-neck obstruction occur.

ATROVENT HFA may interact additively with concomitantly used anticholinergic medications. Avoid administration of ATROVENT HFA with other anticholinergic-containing drugs.

The most common adverse reactions (>5% incidence in the 12-week placebo-controlled trials) were bronchitis, COPD exacerbations, dyspnea and headache.

INDICATION

ATROVENT HFA is an anticholinergic indicated for the maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.

Please see full Prescribing Information, including Instructions for Use, for ATROVENT HFA.